Based on these results, inhibition of Hsp70 alone did not seem to be a promising strategy, so, to overcome tumor cell resistance to anticancer drugs, we used an HSF1 inhibitor that is able to reduce the expression of Hsp90, Hsp70, and Hsp 40 simultaneously [19]. This evidence concerns the gene HSF1 and neoplasm.